Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries.
Ko M, Frivold C, Mvundura M, Soble A, Gregory C, Christiansen H, Hasso-Agopsowicz M, Fu H, Jit M, Hsu S, Mistilis JJ, Scarna T, Earle K, Menozzi-Arnaud M, Giersing B, Jarrahian C, Yakubu A, Malvolti S, Amorij JP. Ko M, et al. Among authors: amorij jp. Vaccines (Basel). 2024 Sep 19;12(9):1075. doi: 10.3390/vaccines12091075. Vaccines (Basel). 2024. PMID: 39340105 Free PMC article.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Scarnà T, Menozzi-Arnaud M, Friede M, DeMarco K, Plopper G, Hamer M, Chakrabarti A, Gilbert PA, Jarrahian C, Mistilis J, Hesselink R, Gandrup-Marino K, Amorij JP, Giersing B. Scarnà T, et al. Among authors: amorij jp. Expert Opin Drug Deliv. 2023 Mar;20(3):315-322. doi: 10.1080/17425247.2023.2168641. Epub 2023 Jan 27. Expert Opin Drug Deliv. 2023. PMID: 36649573 Free article.
Estimating the future global dose demand for measles-rubella microarray patches.
Ko M, Malvolti S, Cherian T, Mantel C, Biellik R, Jarrahian C, Menozzi-Arnaud M, Amorij JP, Christiansen H, Papania MJ, Meltzer MI, Masresha BG, Pastor D, Durrheim DN, Giersing B, Hasso-Agopsowicz M. Ko M, et al. Among authors: amorij jp. Front Public Health. 2023 Jan 16;10:1037157. doi: 10.3389/fpubh.2022.1037157. eCollection 2022. Front Public Health. 2023. PMID: 36726626 Free PMC article.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Hasso-Agopsowicz M, Crowcroft N, Biellik R, Gregory CJ, Menozzi-Arnaud M, Amorij JP, Gilbert PA, Earle K, Frivold C, Jarrahian C, Mvundura M, Mistilis JJ, Durrheim DN, Giersing B. Hasso-Agopsowicz M, et al. Among authors: amorij jp. Front Public Health. 2022 Mar 2;10:809675. doi: 10.3389/fpubh.2022.809675. eCollection 2022. Front Public Health. 2022. PMID: 35309224 Free PMC article. Review.
The effect of formulation on spray dried Sabin inactivated polio vaccine.
Kanojia G, Ten Have R, Brugmans D, Soema PC, Frijlink HW, Amorij JP, Kersten G. Kanojia G, et al. Among authors: amorij jp. Eur J Pharm Biopharm. 2018 Aug;129:21-29. doi: 10.1016/j.ejpb.2018.05.021. Epub 2018 May 19. Eur J Pharm Biopharm. 2018. PMID: 29787800 Free article.
45 results